Financhill
Back

United States Cellular Vs. Keros Therapeutics Industry Stock Comparison

Buy
64

USM
United States Cellular

Last Price:
52.81
Seasonality Move:
4.68%
Buy
66

KROS
Keros Therapeutics

Last Price:
49.74
Seasonality Move:
16.51%
Buy
64
United States Cellular (USM) is a Buy

Is United States Cellular a Buy, Sell or Hold?

  • The current United States Cellular [USM] share price is $54.01. The Score for USM is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • USM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Keros Therapeutics (KROS) is a Buy

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $50.82. The Score for KROS is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • KROS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

USM Stock Price Chart

What is United States Cellular's stock price today?

  • The United States Cellular share price today is $54.01
    The current trend is moderately bearish and USM is experiencing selling pressure, which indicates risk of future bearish movement.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $50.82
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing buying pressure, which is a positive indicator for future bullish movement.

USM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.1 Buy
Relative Strength Index (14 RSI): 45.83 Sell
Chaikin Money Flow: -161635 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.78 - 57.08) Sell
Bollinger Bands (100): (35.02 - 53.38) Buy

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.55 Buy
Relative Strength Index (14 RSI): 60.14 Buy
Chaikin Money Flow: 281726 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.12 - 48.88) Buy
Bollinger Bands (100): (47.03 - 63.59) Sell

USM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.76 Sell
20-day SMA: 56.08 Sell
50-day SMA: 52.57 Buy
200-day SMA: 43.02 Buy
8-day EMA: 56.14 Sell
20-day EMA: 55.66 Sell
50-day EMA: 52.05 Buy
200-day EMA: 42.87 Buy

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.52 Buy
20-day SMA: 46.13 Buy
50-day SMA: 48.03 Buy
200-day SMA: 48.13 Buy
8-day EMA: 48.75 Buy
20-day EMA: 47.51 Buy
50-day EMA: 48.96 Buy
200-day EMA: 49.47 Buy

United States Cellular Earnings Growth & USM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.56 per share, and an increase next year of $2.95 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

United States Cellular Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):